Antithrombotic Therapy for VTE Disease
CHEST JournalPublished 7 January 2016
Clive Kearon, Elie A. Akl, Joseph Ornelas, Allen J. Blaivas, David Jiménez, Henri Bounameaux
Citations4,789
SJR quartileQ1
SJR score1.83
SNIP1.83
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Recommendations on 12 topics that were in the 9th edition of these guidelines are updated, and 3 new topics are addressed.
Abstract
Of 54 recommendations included in the 30 statements, 20 were strong and none was based on high-quality evidence, highlighting the need for further research.
Keywords
Medicine
BMJThe Cochrane Collaboration's tool for assessing risk of bias in randomised trials
34,210 Citations2011Julian P. T. Higgins, Doug Altman +10 more
The Cochrane Collaboration’s tool for assessing risk of bias aims to make the process clearer and more accurate.
Journal of Clinical EpidemiologyGRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
10,460 Citations2011Gordon Guyatt, Andrew D Oxman +8 more
The GRADE process begins with asking an explicit question, including specification of all important outcomes, and provides explicit criteria for rating the quality of evidence that include study design, risk of bias, imprecision, inconsistency, indirectness, and magnitude of effect.
Journal of Clinical EpidemiologyGRADE guidelines: 3. Rating the quality of evidence
8,174 Citations2011Howard Balshem, Mark Helfand +8 more
The approach of GRADE to rating quality of evidence specifies four categories-high, moderate, low, and very low-that are applied to a body of evidence, not to individual studies.
European Heart JournalGuidelines on the diagnosis and management of acute pulmonary embolism
2,821 Citations2008Adam Torbicki, Arnaud Perrier +47 more
Journal of Clinical EpidemiologyGRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
2,702 Citations2011Gordon Guyatt, Andrew D Oxman +8 more
In the GRADE approach, randomized trials start as high-quality evidence and observational studies as low- quality evidence, but both can be rated down if most of the relevant evidence comes from studies that suffer from a high risk of bias.
CHEST JournalPrevention of VTE in Nonsurgical Patients
2,685 Citations2012Susan R. Kahn, Wendy Lim +10 more
Decisions regarding prophylaxis in nonsurgical patients should be made after consideration of risk factors for both thrombosis and bleeding, clinical context, and patients' values and preferences.
New England Journal of MedicineDabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2,571 Citations2009Sam Schulman, Clive Kearon +7 more
For the treatment of acute venous thromboembolism, a fixed dose of dabigatran is as effective as warfarin, has a safety profile that is similar to that of warfar in, and does not require laboratory monitoring.
Journal of Clinical EpidemiologyGRADE guidelines 6. Rating the quality of evidence—imprecision
2,506 Citations2011Gordon Guyatt, Andrew D Oxman +18 more
It is suggested that examination of 95% confidence intervals (CIs) provides the optimal primary approach to decisions regarding imprecision and rating down the quality of evidence is required if clinical action would differ if the upper versus the lower boundary of the CI represented the truth.
New England Journal of MedicineOral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2,321 Citations2012Non Renseigné
A fixed-dose regimen of rivaroxaban alone was noninferior to standard therapy for the initial and long-term treatment of pulmonary embolism and had a potentially improved benefit-risk profile.
The LancetIndications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
2,289 Citations1994Fibrinolytic Therapy Trialists' Collaborative Group
New England Journal of MedicineOral Apixaban for the Treatment of Acute Venous Thromboembolism
2,283 Citations2013Giancarlo Agnelli, Harry R. Büller +9 more
A fixed-dose regimen of apixaban alone was noninferior to conventional therapy for the treatment of acute venous thromboembolism and was associated with significantly less bleeding.
Borås Academic Digital Archive (University of Borås)Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
2,230 Citations1994Johan Herlitz
It is shown that fibrinolytic therapy can reduce mortality in patients with suspected acute myocardial infarction (AMI) and the indications for, and contraindications to, this therapy.
CirculationManagement of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2,210 Citations2011Michael R. Jaff, M. Sean McMurtry +11 more
The goal is to provide practical advice to enable the busy clinician to optimize the management of patients with these severe manifestations of VTE, including massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension.
CHEST JournalPrevention of VTE in Orthopedic Surgery Patients
1,905 Citations2012Yngve Falck–Ytter, Charles W. Francis +7 more
Optimal strategies for thromboprophylaxis after major orthopedic surgery include pharmacologic and mechanical approaches.
BloodRecurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
1,856 Citations2002Paolo Prandoni, Anthonie W.A. Lensing +9 more
Possibility for improvement using the current paradigms of anticoagulation seem limited and new treatment strategies should be developed, as cancer patients with venous thrombosis are more likely to develop recurrent thromboembolic complications and major bleeding during anticoaggerant treatment than those without malignancy.
Journal of Clinical EpidemiologyGRADE guidelines: 8. Rating the quality of evidence—indirectness
1,753 Citations2011Gordon Guyatt, Andrew D Oxman +15 more
Decisions regarding indirectness of patients and interventions depend on an understanding of whether biological or social factors are sufficiently different that one might expect substantial differences in the magnitude of effect.
Journal of Clinical EpidemiologyGRADE guidelines: 5. Rating the quality of evidence—publication bias
1,750 Citations2011Gordon Guyatt, Andrew D Oxman +13 more
In the GRADE approach, randomized trials start as high-quality evidence and observational studies as low- quality evidence, but both can be rated down if a body of evidence is associated with a high risk of publication bias.
CHEST JournalOral Anticoagulant Therapy
1,475 Citations2012Walter Ageno, Alexander Gallus +4 more
There is a large amount of evidence on laboratory and clinical characteristics of vitamin K antagonists and a growing body of evidence is becoming available on the first new oral anticoagulant drugs available for clinical use, dabigatran and rivaroxaban.
CHEST JournalVTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
1,471 Citations2012Shannon M. Bates, Ian A. Greer +4 more
This guideline focuses on the management of VTE and thrombophilia as well as the use of antithrombotic agents during pregnancy and recommends low-molecular-weight heparin for the prevention and treatment of V TE in pregnant women.
Journal of Clinical EpidemiologyGRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations
1,406 Citations2013Jeff Andrews, Gordon Guyatt +13 more
The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach to classifying the direction and strength of recommendations is described, separated into strong and weak.
New England Journal of MedicineRiociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
1,382 Citations2013Hossein-Ardeschir Ghofrani, Andrea Maria D’Armini +11 more
Riociguat significantly improved exercise capacity and pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension.
New England Journal of MedicineApixaban for Extended Treatment of Venous Thromboembolism
1,341 Citations2012Giancarlo Agnelli, Harry R. Büller +7 more
Extended anticoagulation with apixaban at either a treatment dose (5 mg) or a thromboprophylactic dose (2.5mg) reduced the risk of recurrent venous thromboembolism without increasing the rate of major bleeding.
The LancetBleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)
1,338 Citations1996Gualtiero Palareti, Nicoletta Leali +11 more
Caution is required in elderly patients and anticoagulation intensity should be closely monitored to reduce periods of overdosing and see fewer bleeding events than those recorded in other observational and experimental studies.
Journal of Clinical EpidemiologyGRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength
1,295 Citations2013Jeffrey C Andrews, Holger J. Schünemann +16 more
This article addresses GRADE's approach to determining the direction and strength of a recommendation, which describes the balance of desirable and undesirable outcomes of interest among alternative management strategies depending on four domains, namely estimates of effect for desirable and desirable outcomes ofinterest, confidence in the estimates ofEffect, estimates of values and preferences, and resource use.
Journal of Clinical EpidemiologyGRADE guidelines: 9. Rating up the quality of evidence
1,258 Citations2011Gordon Guyatt, Andrew D Oxman +18 more
Systematic review authors and guideline developers may also consider rating up quality of evidence when a dose-response gradient is present, and when all plausible confounders or biases would decrease an apparent treatment effect, or would create a spurious effect when results suggest no effect.
Archives of Internal MedicineSimplification of the Pulmonary Embolism Severity Index for Prognostication in Patients With Acute Symptomatic Pulmonary Embolism
1,246 Citations2010David Jiménez
The simplified PESI has similar prognostic accuracy and clinical utility and greater ease of use compared with the original PESi and is applicable to outpatients with acute pulmonary embolism.
The Lancet NeurologyCerebral venous thrombosis: an update
1,226 Citations2007Marie‐Germaine Bousser, José M. Ferro
MRI with T1, T2, fluid-attenuated inversion recovery, and T2* sequences combined with magnetic resonance angiography are the best diagnostic methods for CVT.
CHEST JournalGrading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
1,214 Citations2006Gordon Guyatt, David D. Gutterman +7 more
An American College of Chest Physicians task force formulated the criteria for a grading system to be utilized in all ACCP guidelines that included simplicity and transparency, explicitness of methodology, and consistency with current methodological approaches to the grading process.
New England Journal of MedicineA Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis
1,198 Citations1996Mark Levine, Michael Gent +17 more
Low-molecular-weight heparin can be used safely and effectively to treat patients with proximal deep-vein thrombosis at home.
New England Journal of MedicineTreatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home
1,120 Citations1996Maria M.W. Koopman, Paolo Prandoni +14 more
In patients with proximal-vein thrombosis, treatment with low-molecular-weight heparin at home is feasible, effective, and safe.
CirculationRandomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
1,110 Citations2013Nils Kucher, Peter Boekstegers +17 more
In patients with pulmonary embolism at intermediate risk, a standardized USAT regimen was superior to anticoagulation with heparin alone in reversing RV dilatation at 24 hours, without an increase in bleeding complications.
Journal of the American College of CardiologyComparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation
1,080 Citations2010Gregory Y.H. Lip, Lars Frison +2 more
Of the contemporary bleeding risk stratification schemas, the new HAS-BLED scheme offers useful predictive capacity for bleeding over previously published schemas and may be simpler to apply.
Annals of Internal MedicinePrediction of Pulmonary Embolism in the Emergency Department: The Revised Geneva Score
1,071 Citations2006Grégoire Le Gal, Marc Righini +5 more
A new prediction rule is derived that is entirely based on clinical variables and is independent of physicians' implicit judgment by using a large multicenter cohort of patients admitted to the emergency department for clinically suspected pulmonary embolism.
CirculationChronic Thromboembolic Pulmonary Hypertension (CTEPH)
1,049 Citations2011Joanna Pepke‐Żaba, Marion Delcroix +23 more
Despite similarities in clinical presentation, operable and nonoperable CTEPH patients may have distinct associated medical conditions.
New England Journal of MedicineHeparin plus Alteplase Compared with Heparin Alone in Patients with Submassive Pulmonary Embolism
982 Citations2002Stavros Konstantinides, Annette Geibel +3 more
When given in conjunction with heparin, alteplase can improve the clinical course of stable patients who have acute submassive pulmonary embolism and can prevent clinical deterioration requiring the escalation of treatment during the hospital stay.
New England Journal of MedicineA Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism
936 Citations1995Sam Schulman, Ann-Sofie Rhedin +15 more
Six months of prophylactic oral anticoagulant treatment after a first episode of venous thromboembolism led to a lower recurrence rate than did treatment lasting for six weeks, and the rates of recurrence remained nearly parallel for 1 1/2 years thereafter.
CirculationTreatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
932 Citations2013Sam Schulman, Ajay K. Kakkar +9 more
Dabigatran has similar effects on VTE recurrence and a lower risk of bleeding compared with warfarin for the treatment of acute VTE.
Annals of Internal MedicineRisk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
920 Citations1994Elaine M. Hylek, Daniel E. Singer
The results emphasize the importance of maintaining the prothrombin time ratios under 2.0 and the need for especially careful use of warfarin in the elderly.
New England Journal of MedicineSubcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary Embolism
888 Citations2003The Matisse Investigators
Once-daily, subcutaneous administration of fondaparinux without monitoring is at least as effective and is as safe as adjusted-dose, intravenous administration of unfractionated heparin in the initial treatment of hemodynamically stable patients with pulmonary embolism.
Journal of the American College of CardiologyA New Risk Scheme to Predict Warfarin-Associated Hemorrhage
850 Citations2011Margaret C. Fang, Alan S. Go +5 more
A simple 5-variable risk score was effective in quantifying the risk of warfarin-associated hemorrhage in a large community-based cohort of patients with atrial fibrillation.
Annals of Internal MedicineDeterminants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis
847 Citations2008Susan R. Kahn, Ian Shrier +13 more
JAMAThrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage
804 Citations2014Saurav Chatterjee, Anasua Chakraborty +8 more
Among patients with pulmonary embolism, including those who were hemodynamically stable with right ventricular dysfunction, thrombolytic therapy was associated with lower rates of all-cause mortality and increased risks of major bleeding and ICH.
New England Journal of MedicineLow-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism
787 Citations1997The Columbus Investigators
Fixed-dose, subcutaneous low-molecular-weight heparin is as effective and safe as adjusted- dose, intravenous unfractionated Heparin for the initial management of venous thromboembolism, regardless of whether the patient has pulmonary embolism or a history of venOUS thrombolism.
New England Journal of MedicineA Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary Embolism
784 Citations1997Gérald Simonneau, Hervé Sors +10 more
Under the conditions of this study, initial subcutaneous therapy with the low-molecular-weight heparin tinzaparin appeared to be as effective and safe as intravenous unfractionated Heparin in patients with acute pulmonary embolism.
HaematologicaThe risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients
770 Citations2007Paolo Prandoni, Franco Noventa +8 more
Besides unprovoked presentation, other factors independently associated with a statistically significant increased risk of recurrent VTE are thrombophilia, clinical presentation with primary DVT, shorter duration of anticoagulation, and increasing age.
CirculationMassive Pulmonary Embolism
770 Citations2006Nils Kucher, Elisa Rossi +2 more
Counterintuitively, thrombolysis did not reduce mortality or recurrent PE at 90 days, and IVC filters were associated with a reduction in 90-day mortality.
The Annals of Thoracic SurgeryPulmonary endarterectomy: experience and lessons learned in 1,500 cases
768 Citations2003Stuart W. Jamieson, David P. Kapelanski +7 more
The pulmonary endarterectomy operation is considered curative and therefore greatly superior to transplantation for this condition and current techniques of operation make the procedure relatively safe.
New England Journal of MedicineChronic Thromboembolic Pulmonary Hypertension
767 Citations2001Peter F. Fedullo, William R. Auger +2 more
PubMedClinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis.
761 Citations2003Lori‐Ann Linkins, P. Choi +1 more
A meta-analysis of studies involving patients with venous thromboembolism who received at least 3 months of oral anticoagulant therapy with a target international normalized ratio (INR) of 2.0 to 3.0 obtained reliable estimates of the clinical impact of anticogulant-related bleeding.
CirculationPrognostic Value of Troponins in Acute Pulmonary Embolism
741 Citations2007Cecilia Becattini, Maria Cristina Vedovati +1 more
A meta-analysis of studies in patients with acute pulmonary embolism to assess the prognostic value of elevated troponin levels for short-term death and adverse outcome events found that these levels were associated with a high mortality in the subgroup of hemodynamically stable patients.
New England Journal of MedicineSubcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
703 Citations1992Russell D. Hull, Gary E. Raskob +16 more
Annals of Internal MedicineRisk Factors for Complications of Chronic Anticoagulation: A Multicenter Study
671 Citations1993Stephan D. Fihn, Mary McDonell +6 more
The incidence of bleeding and thromboembolic complications and related risk factors from a retrospective study of 980 patients followed in five anticoagulation clinics through 1990 are described.
CirculationClinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous Thromboembolism
670 Citations2008Silvy Laporte, Patrick Mismetti +6 more
Annals of Internal MedicineBelow-Knee Elastic Compression Stockings To Prevent the Post-Thrombotic Syndrome
650 Citations2004Paolo Prandoni, Anthonie W.A. Lensing +8 more
A randomized, controlled trial evaluated the efficacy of below-knee compression elastic stockings in preventing the post-thrombotic syndrome in patients with a first episode of acute symptomatic proximal DVT.
Annals of Internal MedicineLow-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous Thrombosis
627 Citations1999Michael K. Gould, Anne D. Dembitzer +3 more
A meta-analysis to incorporate the most recent data from clinical trials, to resolve discrepancies among previous reviews, and to obtain precise estimates of clinically important treatment outcomes is performed.
Annals of Internal MedicineFondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Venous Thrombosis
615 Citations2004Harry R. Büller, Bruce L. Davidson +11 more
A dose-ranging study of deep venous thrombosis treatment found that a once-daily subcutaneous injection of fondaparinux, 7.5 mg, may be effective and safe across a broad range of body weights (50 kg and 100 kg) and Pharmacokinetic analyses suggested that daily doses of 5 mg and 10 mg are appropriate for patients less than and more than that weight range, respectively.
New England Journal of MedicineThe Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism
611 Citations1997Sam Schulman, S. Granqvist +14 more
Prophylactic oral anticoagulation that was continued for an indefinite period after a second episode of venous thromboembolism was associated with a much lower rate of recurrence during four years of follow-up than treatment for six months, however, there was a trend toward a higher risk of major hemorrhage when antICOagulation was continued indefinitely.
New England Journal of MedicineWarfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis
609 Citations1979Russell D. Hull, Terry Delmore +6 more
Adjust-dose warfarin sodium is more effective than low-dose subcutaneous heparin in preventing recurrent venous thromboembolism, but its use is accompanied by a significant risk of bleeding.
Archives of Internal MedicineRecurrent Venous Thromboembolism After Deep Vein Thrombosis
591 Citations2000Per‐Olof Hansson, Jan Sörbo +1 more
Patients with proximal DVT, diagnosed cancer, short duration of oral anticoagulation therapy, or a history of thromboembolic events had a higher risk of recurrent events, while patients with postoperative DVT had a lower recurrence rate.
New England Journal of MedicineThree Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis
589 Citations2001Giancarlo Agnelli, Paolo Prandoni +27 more
In patients with idiopathic deep venous thrombosis, the clinical benefit associated with extending the duration of anticoagulant therapy to one year is not maintained after the therapy is discontinued.
Journal of Thrombosis and HaemostasisInternational clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
589 Citations2012Dominique Farge, P. Debourdeau +24 more
The use of LMWH for VTE prevention in cancer patients undergoing laparoscopic surgery may be recommended as for laparotomy and mechanical methods are not recommended as monotherapy except when pharmacological methods are contraindicated.
The LancetComparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis
588 Citations1992Paolo Prandoni, Mariarosa Carta +7 more
It is concluded that fixed-dose subcutaneous LMWH is at least as effective and safe as intravenous adjusted-dose heparin in the initial treatment of symptomatic proximal-vein thrombosis and since there is no need for laboratory monitoring with the LMWH regimen, patients with venous thromBosis can be treated at home.
The LancetOutpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial
577 Citations2011Drahomir Aujesky, Pierre‐Marie Roy +17 more
In selected low-risk patients with pulmonary embolism, outpatient care can safely and effectively be used in place of inpatient care.
Canadian Medical Association JournalIdentifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
567 Citations2008Marc Rodger, Susan R. Kahn +12 more
Women with 0 or 1 risk factor may safely discontinue oral anticoagulant therapy after 6 months of therapy following a first unprovoked venous thromboembolism, and this criterion does not apply to men.
BMJUse of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive
557 Citations2008Roman Jaeschke, Gordon Guyatt +7 more
The large and diverse nature of guideline committees can make consensus difficult, so Roman Jaeschke and colleagues describe a simple technique for clarifying opinion.
New England Journal of MedicineLow-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
547 Citations2012Timothy Brighton, John W. Eikelboom +10 more
The results substantiate earlier evidence of a therapeutic benefit of aspirin when it is given to patients after initial anticoagulant therapy for a first episode of unprovoked venous thromboembolism and result in a significant reduction in the rate of major vascular events, with improved net clinical benefit.
Archives of Internal MedicineBleeding complications in oral anticoagulant therapy. An analysis of risk factors
542 Citations1993F J van der Meer
The risk of bleeding complications rises significantly with age and with the achieved intensity of anticoagulation, and is dependent on the type of coumarin derivative that is used.
Annals of Internal MedicineResidual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism
536 Citations2002Paolo Prandoni, Anthonie W.A. Lensing +10 more
Recurrent thromboembolism was more frequent among those showing persistent residual thrombosis rather than early vein recanalization and might help clinicians adjust the duration of oral anticoagulant therapy on an individual basis in patients who have had an episode of DVT.
European Heart JournalPrognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review
532 Citations2008Olivier Sanchez, Ludovic Trinquart +5 more
RV dysfunction assessed by CT, echocardiography, or by cardiac biomarkers are all associated with an increased risk of mortality in patients with haemodynamically stable PE.
CirculationBalloon Pulmonary Angioplasty for Treatment of Chronic Thromboembolic Pulmonary Hypertension
528 Citations2001Jeffrey A. Feinstein, Samuel Z. Goldhaber +3 more
BPA reduces pulmonary artery hypertension in patients withCTEPH and is associated with long-term improvement in New York Heart Association class and 6-minute walking distances and is a promising interventional technique that warrants randomized comparison with medical therapy in CTEPH patients who are not surgical candidates.
The LancetCompression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial
523 Citations2013Susan R. Kahn, Stan Shapiro +27 more
ECS did not prevent PTS after a first proximal DVT, hence the findings do not support routine wearing of ECS after DVT.
Journal of Thrombosis and HaemostasisEffectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta‐analysis
522 Citations2013Tom van der Hulle, Judith Kooiman +4 more
A meta‐analysis was performed to determine the efficacy and safety of NOACs as compared with those of VKAs in patients with acute VTE.
New England Journal of MedicineHeparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis
511 Citations1990Russell D. Hull, Gary E. Raskob +7 more
It is concluded that a five-day course of heparin is as effective as a 10- day course in treating deep venous thrombosis and furthermore, using the shorter course would permit earlier discharge from the hospital and thus offer substantial cost savings.
CirculationRisk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism
502 Citations2010Sabine Eichinger, Georg Heinze +2 more
By use of a simple scoring system, the assessment of the recurrence risk in patients with a first unprovoked VTE and without strong thrombophilic defects can be improved.
Journal of Vascular and Interventional RadiologyCatheter-directed Therapy for the Treatment of Massive Pulmonary Embolism: Systematic Review and Meta-analysis of Modern Techniques
499 Citations2009William T. Kuo, Michael K. Gould +4 more
Modern CDT is a relatively safe and effective treatment for acute massive PE and at experienced centers, CDT should be considered as a first-line treatment for patients with massive PE.
Annals of Internal MedicineThe Role of Venous Ultrasonography in the Diagnosis of Suspected Deep Venous Thrombosis and Pulmonary Embolism
486 Citations1998Clive Kearon, Jeffrey S. Ginsberg +1 more
The strengths and weaknesses of venous ultrasonography are considered in patients with the five clinical presentations of suspected venous thromboembolism and the criteria used to diagnose thrombosis often vary among examiners.
Archives of Internal MedicineA Meta-analysis Comparing Low-Molecular-Weight Heparins With Unfractionated Heparin in the Treatment of Venous Thromboembolism
467 Citations2000Lisa Dolovich, Jeffrey S. Ginsberg +3 more
Low-molecular-weight heparins are at least as effective as UFH in preventing recurrent VTE and it is unlikely that LMWHs are superior in the treatment of VTE, but they do show a statistically significant decrease in total mortality.
StrokeThe Incidence of Cerebral Venous Thrombosis
465 Citations2012Jonathan M. Coutinho, Susanna M. Zuurbier +2 more
The incidence of cerebral venous thrombosis among adults is probably higher than previously believed.
Annals of Internal MedicineSystematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism
460 Citations2010Marc Carrier, Grégoire Le Gal +2 more
The case-fatality rate of recurrent VTE decreases after completion of the initial period of anticoagulation and major bleeding events are similar during theInitial period of VTE treatment, suggesting that clinicians have a surrogate measure of mortality to balance the risks and benefits of antICOagulant therapy in patients with VTE.
PubMedUpper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications.
456 Citations1997Paolo Prandoni, P. Polistena +9 more
CirculationImportance of Cardiac Troponins I and T in Risk Stratification of Patients With Acute Pulmonary Embolism
448 Citations2002Stavros Konstantinides, Annette Geibel +5 more
Cardiac troponins I and cTnT may be a novel, particularly useful tool for optimizing the management strategy in patients with acute PE, and there was obvious escalation of in-hospital mortality, the rate of complications, and the incidence of recurrent PE.
Archives of Internal MedicineBleeding Complications in Oral Anticoagulant Therapy
433 Citations1993F.J.M. van der Meer
The risk of bleeding complications rises significantly with age and with the achieved intensity of anticoagulation, and is dependent on the type of coumarin derivative that is used.
Cochrane Database of Systematic ReviewsFixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism
433 Citations2004Carlo J van Dongen, Angelique GM van den Belt +2 more
A sub-analysis of these trials showed statistically significant reductions favouring the action of low molecular weight heparin in three areas: thrombotic complications; major haemorrhages; and overall mortality.
CirculationPulmonary Embolism
433 Citations1999Ary Ribeiro, Per Lindmarker +3 more
An echocardiography Doppler investigation performed 6 weeks after diagnosis of acute PE can identify patients with persistent PH/RV dysfunction and may be of value in planning the follow-up and care of these patients.
CHEST JournalIncidence of Chronic Thromboembolic Pulmonary Hypertension After a First Episode of Pulmonary Embolism
414 Citations2006Cecilia Becattini, Giancarlo Agnelli +5 more
The incidence of chronic thromboembolic pulmonary hypertension after the first episode of objectively confirmed pulmonary embolism was about 1%, and a diagnosis of CTPH was confirmed in two patients with idiopathic PE.
Journal of Thoracic and Cardiovascular SurgeryModern surgical treatment of massive pulmonary embolism: Results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach
407 Citations2005Marzia Leacche, Daniel Unić +9 more
Archives of Internal MedicineRelationship Between Deep Venous Thrombosis and the Postthrombotic Syndrome
407 Citations2004Susan R. Kahn, Jeffrey S. Ginsberg
Preventing DVT with the use of effective thromboprophylaxis in high-risk patients and settings and minimizing the risk of ipsilateral DVT recurrence are likely to reduce therisk of development of PTS.
Annals of Internal MedicineExtended Oral Anticoagulant Therapy after a First Episode of Pulmonary Embolism
395 Citations2003Giancarlo Agnelli, Paolo Prandoni +11 more
A multicenter randomized trial to evaluate the long-term clinical benefit of extending a 3-month course of oral anticoagulant therapy to 6 months or to 1 year in patients with a first episode of pulmonary embolism.
New England Journal of MedicineFondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs
391 Citations2010Hervé Decousus, P. Prandoni +9 more
Fondaparinux at a dose of 2.5 mg once a day for 45 days was effective in the treatment of patients with acute, symptomatic superficial-vein thrombosis of the legs and did not have serious side effects.
Annals of Internal MedicineLow-Molecular-Weight Heparin Compared with Intravenous Unfractionated Heparin for Treatment of Pulmonary Embolism
383 Citations2004Daniel J. Quinlan, Andrew McQuillan +1 more
A meta-analysis of 12 randomized trials compared the 2 heparin-based therapies and found nonstatistically significant reductions in risks for recurrent thromboembolism and major bleeding with low-molecular-weight hepar in patients with pulmonary embolus.
CirculationUpper-Extremity Deep Vein Thrombosis
379 Citations2004Hylton V. Joffe, Nils Kucher +2 more
The findings identify deficiencies in the current understanding and the prophylaxis of UEDVT and generate hypotheses for future research efforts that differ from the conventional risk factors for lower-extremity DVT.
Journal of Thrombosis and HaemostasisSubsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta‐analysis of the management outcome studies
378 Citations2010Marc Carrier, Marc Righini +6 more
Multiple‐detectors CTPA seems to increase the proportion of patients diagnosed with subsegmental PE without lowering the 3‐month risk of thromboembolism suggesting that subse segmental PE may not be clinically relevant.
The LancetRANDOMISED CONTROLLED TRIAL OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR VERSUS UROKINASE IN THE TREATMENT OF ACUTE PULMONARY EMBOLISM
371 Citations1988SamuelZ. Goldhaber, John A. Heit +16 more
In the dose regimens employed, rt-PA acts more rapidly and is safer than urokinase in the treatment of acute PE, and improvement in lung scan reperfusion at 24 h was identical in the two treatment groups.
RadiologyInferior Vena Caval Filters: Review of a 26-year Single-Center Clinical Experience
370 Citations2000Christos A. Athanasoulis, John A. Kaufman +4 more
Inferior vena caval filters provide protection from life-threatening PE, with minimal morbidity, during a 26-year single-center clinical experience with inferior vena Caval filters.
Archives of Internal MedicineRisk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor
368 Citations2010Alfonso Iorio, Clive Kearon +6 more
The risk of recurrence is low if VTE is provoked by surgery, intermediate if provoked by a nonsurgical risk factor, and high if unprovoked, which affects whether patients with VTE should undergo short-term vs indefinite treatment.
Journal of Vascular SurgeryCatheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life
360 Citations2000Anthony J. Comerota, Richard C. Throm +3 more
Patients with iliofemoral DVT treated with catheter-directed thrombolysis with urokinase have better functioning and well-being, compared with patients treated with anticoagulation alone.
HepatologyDeterminants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome
358 Citations2004Sarwa Darwish Murad, Dominique Valla +8 more
Patients with BCS can be classified into good (I), intermediate (II), and poor (III) prognostic classes, according to simple baseline clinical and laboratory parameters, and an improved survival after surgical portosystemic shunting is suggested.
BMJComparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
346 Citations2015Neena S. Abraham, Sonal Singh +5 more
BloodVena caval filters: a comprehensive review
339 Citations2000Michael B. Streiff
Vena caval filters represent a potentially important but poorly evaluated therapeutic modality in the prevention of pulmonary emboli and Randomized trials are necessary to establish the appropriate place for vena Caval filters in the treatment of venous thromboembolic disease.
Annals of Internal MedicineSuperficial Venous Thrombosis and Venous Thromboembolism
335 Citations2010Hervé Decousus, Isabelle Quéré +11 more
A substantial number of patients with SVT exhibit venous thromboembolism at presentation, and some that do not can develop this complication in the subsequent 3 months.
…